May 2, 2017 / 12:37 PM / 5 months ago

BRIEF-Abeona Therapeutics provides update on EB-101 gene therapy

May 2 (Reuters) - Abeona Therapeutics Inc

* Abeona Therapeutics provides update on EB-101 gene therapy for severe form of epidermolysis bullosa from the society for investigative dermatology conference

* EB-101 demonstrates significant wound healing in 100 pct of treated wounds at 3 months; 89 pct at 6 months, 83 pct at 12 months Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below